Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisuke Yabe

Showing results (171-180 of 253) with videos related to

Pageof 26
Sort By:
Plos One|December 13, 2023
Lifestyle factors associated with a rapid decline in the estimated glomerular filtration rate over two years in older adults with type 2 diabetes-Evidence from a large national database in JapanYaya Li, Makoto Fujii, Yuko Ohno, et al.
Journal of Diabetes Investigation|July 11, 2024
A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes - 2nd edition (English version)Ryotaro Bouchi, Tatsuya Kondo, Yasuharu Ohta, et al.
Diabetologia|December 26, 2015
Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trialHitoshi Kuwata, Masahiro Iwasaki, Shinobu Shimizu, et al.
The Journal of Clinical Endocrinology and Metabolism|July 18, 2025
The significance of high expression of circulating miR-222-3p in patients with unilateral primary aldosteronismKentaro Okamoto, Masakatsu Sone, Daisuke Taura, et al.
The Journal of Physiological Sciences : JPS|May 20, 2026
Weight loss by sodium-glucose co-transporter 2 inhibitor canagliflozin is followed by rebound in db/db mice but maintained in fat-fed mice via circadian rises in body temperature and locomotor activityLei Wang, Wanxin Han, Dauren Zhantleu, et al.
JTCVS Open|October 31, 2025
Impact of excessive body fat mass on mortality after lung transplantationAyako Oshima, Susumu Sato, Yohei Oshima, et al.
Journal of Diabetes Investigation|November 26, 2014
Relationship and factors responsible for regulating fasting and post-challenge plasma glucose levels in the early stage development of type 2 diabetes mellitusSae Aoyama-Sasabe, Xin Xin, Ataru Taniguchi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 22, 2019
Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretionYanyan Liu, Shin-Ichi Harashima, Yu Wang, et al.
Diabetology International|January 22, 2021
Effect of linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulfonylurea glimepiride on cardiovascular outcomes in Asians with type 2 diabetes: subgroup analysis of the randomized CAROLINA® trialTakashi Kadowaki, Guang Wang, Julio Rosenstock, et al.
Journal of the Endocrine Society|January 6, 2022
First Japanese Family With <i>PDX1</i>-MODY (MODY4): A Novel <i>PDX1</i> Frameshift Mutation, Clinical Characteristics, and ImplicationsSatoshi Yoshiji, Yukio Horikawa, Sodai Kubota, et al.
Pageof 26

Showing results (171-180 of 253) with videos related to

Sort By:
Pageof 26
Plos One|December 13, 2023
Lifestyle factors associated with a rapid decline in the estimated glomerular filtration rate over two years in older adults with type 2 diabetes-Evidence from a large national database in JapanYaya Li, Makoto Fujii, Yuko Ohno, et al.
Journal of Diabetes Investigation|July 11, 2024
A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes - 2nd edition (English version)Ryotaro Bouchi, Tatsuya Kondo, Yasuharu Ohta, et al.
Diabetologia|December 26, 2015
Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trialHitoshi Kuwata, Masahiro Iwasaki, Shinobu Shimizu, et al.
The Journal of Clinical Endocrinology and Metabolism|July 18, 2025
The significance of high expression of circulating miR-222-3p in patients with unilateral primary aldosteronismKentaro Okamoto, Masakatsu Sone, Daisuke Taura, et al.
The Journal of Physiological Sciences : JPS|May 20, 2026
Weight loss by sodium-glucose co-transporter 2 inhibitor canagliflozin is followed by rebound in db/db mice but maintained in fat-fed mice via circadian rises in body temperature and locomotor activityLei Wang, Wanxin Han, Dauren Zhantleu, et al.
JTCVS Open|October 31, 2025
Impact of excessive body fat mass on mortality after lung transplantationAyako Oshima, Susumu Sato, Yohei Oshima, et al.
Journal of Diabetes Investigation|November 26, 2014
Relationship and factors responsible for regulating fasting and post-challenge plasma glucose levels in the early stage development of type 2 diabetes mellitusSae Aoyama-Sasabe, Xin Xin, Ataru Taniguchi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 22, 2019
Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretionYanyan Liu, Shin-Ichi Harashima, Yu Wang, et al.
Diabetology International|January 22, 2021
Effect of linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulfonylurea glimepiride on cardiovascular outcomes in Asians with type 2 diabetes: subgroup analysis of the randomized CAROLINA® trialTakashi Kadowaki, Guang Wang, Julio Rosenstock, et al.
Journal of the Endocrine Society|January 6, 2022
First Japanese Family With <i>PDX1</i>-MODY (MODY4): A Novel <i>PDX1</i> Frameshift Mutation, Clinical Characteristics, and ImplicationsSatoshi Yoshiji, Yukio Horikawa, Sodai Kubota, et al.
Pageof 26